The Beersheva District Court rejected the Histadrut's claim that Teva had acted in bad faith.
Elbit Imaging has agreed to sell up to 50% of Elbit Medical to Exigent Capital at a 6% discount.
The LR Group won a tender by the Ministry of Jerusalem Affairs and Heritage and the Jerusalem municipality.
Viz.ai uses artificial intelligence to analyze CT scans in order to help doctors diagnose and treat strokes.
Prof. Steven Lamm, in Israel as a consultant to Itamar Medical, tells "Globes" that sleep is more important than physical exercise.
The company also announced the launch of K, a free, first-of-its-kind primary care app along with a new provider network available in New York.
Medtronic and GE Healthcare will receive NIS 50 million each and Change Healthcare will get NIS 20 million to expand Israel operations.
The company has ordered cannabis plant seeds from a Dutch supplier for its farm, which the company is setting up in Uganda.
NewStem’s technology can predict patients’ resistance to chemotherapy allowing for better, targeted cancer treatments and the potential to reduce resistance to chemotherapy.
Biogen CEO Michel Vounatsos seeks synergy between pharma and technology, and found kindred spirits in Israel.
Restrictions on foreign investors and the government's reluctance to approve exports are inhibiting growth in Israel's medical cannabis sector.
Lior Shalev, grandson of Teva founder Eli Hurvitz, targets the 'double bottom line' - both economic and social profit.
The company's share price has risen 118% since Kare Schultz became CEO in November, and 23.5% in the past month. What has changed?
Amai Proteins designs sweet proteins that do not affect the sugar levels in the blood.
Cannabics seeks to match cannabis compounds to treatment of specific tumors.